Informa adds F1000 Research to Taylor & Francis
Source: RNS|
|
Informa LEI: 5493006VM2LKUPSEDU20
Informa PLC Press Release
10 January 2020
Informa adds F1000 Research to the Taylor & Francis Open Access Portfolio
London: Informa (LSE: INF.L), the International Exhibitions, Events, Information Services and Advanced Learning Group, today announces further investment in developing its Open Access ("OA") publishing capabilities through the addition of F1000 Research Ltd. by Taylor & Francis.
|
Stephen A. Carter, Group Chief Executive, Informa PLC, said: "Under the leadership of Annie Callanan in Taylor & Francis, we are deepening our Open Access and also now our Open Research capabilities." He added: "F1000 Research is a leader in its field, committed to the further development of independent, high quality Open Science and Research. We are delighted to welcome Rebecca Lawrence and the team from F1000 Research, and are committed to the further technology and capability development that Open Research needs." Vitek Tracz, Founder, F1000, said: "F1000 Research is a pioneer of quality and independence, with a deep commitment to Open Science and Research. Taylor & Francis is a great fit culturally and its commitment to further investment and development is timely, given the likely acceleration of Open services." |
F1000 Research Ltd. offers fully managed, open research publishing services directly to research funders, learned societies and institutions, including the Wellcome Trust and the Bill & Melinda Gates Foundation.
Additionally, F1000Research is the leading independent open research publishing platform for scientists and academic scholars. Its innovative platform enables the rapid publication of academic research, whilst maintaining quality and transparency, and providing authors with greater autonomy through the process.
The addition of F1000 Research complements and extends Taylor & Francis's programme of investment to expand our presence and capabilities within the increasingly important OA publishing arena. It follows the addition of leading independent OA journal publisher, Dove Medical Press, in 2017 and ongoing internal investment in developing our range of OA publications and services, with more than 300 OA journals now published across our total journal portfolio of over 2,700 titles.
No financial details of the transaction were disclosed.
|
Enquiries |
|
|
Informa PLC Stephen A. Carter, Group Chief Executive Gareth Wright, Group Finance Director Richard Menzies-Gow, Director of IR & Comms |
+44 (0)20 7017 5771 +44 (0)20 7017 7096 +44 (0)20 3377 3445 |
|
Teneo Strategy Tim Burt / Zoë Watt |
+44 (0)20 7240 2486 |
Notes to Editors
Informa PLC
Informa is a leading international Exhibitions, Events, Information Services and Scholarly Publishing Group with annual revenues approaching £3 billion. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and opportunities to connect and learn. For more information, please visit www.informa.com.
About F1000 Research Ltd.
F1000 Research Ltd. provides innovative open access publishing platforms offering rapid publication and open peer review, whilst supporting data deposition and sharing for the research community.
F1000 Research Ltd.'s own publishing platform, F1000Research, was launched in 2013 and was the first open research publishing platform combining the ability to publish rapidly with functionality to ensure transparency, robustness and reproducibility of research. F1000Research's publishing model combines the benefits of 'pre-printing' (providing rapid publication) with quality and transparency (open data support and invited open peer review) and enables publication within days of submission, followed by open invited peer review.
Building upon the growth and success of its core platform, F1000 Research Ltd. also provides fully managed, open research publishing services directly to research funders and institutions, including Wellcome, the Bill & Melinda Gates Foundation and the Health Research Board Ireland, as well as to other scholarly publishers such as Emerald Publishing. F1000 Research combines opportunities offered by technology with a passion for identifying new ways to validate and share research.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
